Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ina Fetzer"'
Autor:
Nadja Sailer, Ina Fetzer, Melanie Salvermoser, Monika Braun, Doris Brechtefeld, Christian Krendl, Christiane Geiger, Kathrin Mutze, Elfriede Noessner, Dolores J. Schendel, Maja Bürdek, Susanne Wilde, Daniel Sommermeyer
Publikováno v:
Cancers, Vol 14, Iss 8, p 1998 (2022)
The hostile tumor microenvironment (TME) is a major challenge for the treatment of solid tumors with T-cell receptor (TCR)-modified T-cells (TCR-Ts), as it negatively influences T-cell efficacy, fitness, and persistence. These negative influences are
Externí odkaz:
https://doaj.org/article/3b9be45c48f644febde2084b9eeb2afe
Autor:
Ina Fetzer, Michael Farzan, Jesse A. Weber, Neha R. Prasad, Matthew R. Gardner, Meredith E. Davis-Gardner, Barnett Alfant, Amber S. Zhou
Broadly neutralizing antibodies (bNAbs) target five major epitopes on the HIV-1 envelope glycoprotein (Env). The most potent bNAbs have median half-maximal inhibitory concentration (IC(50)) values in the nanomolar range, and the broadest bNAbs neutra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feadcd4a4f3a78c51fb92920d7447729
https://europepmc.org/articles/PMC6384058/
https://europepmc.org/articles/PMC6384058/
Autor:
Barnett Alfant, Jesse A. Weber, Michael Farzan, Meredith E. Davis-Gardner, Ina Fetzer, Matthew R. Gardner, Neha R. Prasad
Publikováno v:
Journal of virology. 92(12)
The human immunodeficiency virus type 1 (HIV-1) entry inhibitor eCD4-Ig is a fusion of CD4-Ig and a coreceptor-mimetic peptide. eCD4-Ig is markedly more potent than CD4-Ig, with neutralization efficiencies approaching those of HIV-1 broadly neutraliz